GoodSleepCo, a leading Australian medical device company, proudly announces the FDA clearance for its groundbreaking hushd™PRO Avera™ oral appliance. This innovative device is prescribed for the effective treatment of snoring and mild to moderate obstructive sleep apnea, offering patients a transformative solution for their sleep health needs.
Designed using state-of-the-art 3D printing technology and medical-grade nylon, coupled with advanced automation and AI-enabled processes, the Avera sets a new standard for oral appliances. Its patient-matched anatomical fit ensures optimal comfort and efficacy, while its low-profile, lightweight design guarantees durability without compromising on usability.
"This FDA clearance marks a significant milestone for GoodSleepCo," remarked Joel Simpson, Founder of the company. "It not only paves the way for Avera's introduction into the United States’ market but also signifies a leap forward in our commitment to enhancing patient care and practitioner efficiency.”
Greg Goodman, Co-Founder added, "We are particularly excited about the expansion of our product portfolio with Avera. By offering a comprehensive suite of devices and apps, we empower healthcare providers to deliver personalized, value-based care that prioritizes patient experience and clinical outcomes."
About GoodSleepCo
GoodSleepCo is dedicated to revolutionizing the landscape of sleep medicine for patients and healthcare providers alike. With a diverse leadership team boasting extensive expertise in sleep diagnostics, treatment, manufacturing, and software development, we are uniquely positioned to address the evolving needs of individuals on their sleep health journey. Our innovative solutions drive efficiency, improve patient satisfaction, and ensure cost-effective, risk-mitigated care delivery. For more information, please visit https://us.goodsleepco.health/.